Loren Pickart Researcher profile: Google Scholar Loren Pickarts publications are closely connected to the GHK and GHK-Cu literature reviewed in this article, especially discussions of copper peptide biology, skin remodeling, extracellular matrix activity, wound-model research, and gene-expression hypotheses
Zero completed human clinical trials have tested BPC-157 for lupus or any autoimmune condition as of 2024, making efficacy claims premature regardless of mechanism
BPC-157 promotes angiogenesis through the Egr-1/NAB2 regulatory loop, which simultaneously activates vessel growth (Egr-1) and provides an internal brake (NAB2) to prevent disorganized growth
Skin penetration depends on formulation, concentration, and application technique
I've changed my opinion, and I do think that BPC-157 after a workout may work better than before a workout or at another time of day
Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, White LR: Parkinsonian signs and substantia nigra neuron density in decendents elders without PD
.jpg_01.jpeg)
